Details for New Drug Application (NDA): 017952
✉ Email this page to a colleague
NDA 017952 describes TRIMPEX 200, which is a drug marketed by Roche and is included in one NDA. Additional details are available on the TRIMPEX 200 profile page.
The generic ingredient in TRIMPEX 200 is trimethoprim. There are thirty-four drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the trimethoprim profile page.
The generic ingredient in TRIMPEX 200 is trimethoprim. There are thirty-four drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the trimethoprim profile page.
Summary for 017952
| Tradename: | TRIMPEX 200 |
| Applicant: | Roche |
| Ingredient: | trimethoprim |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017952
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
| Approval Date: | Nov 9, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
